| Literature DB >> 26870003 |
Alena Janda1, Anthony Bowen1, Neil S Greenspan2, Arturo Casadevall3.
Abstract
The adaptive humoral immune response is responsible for the generation of antimicrobial proteins known as immunoglobulin molecules or antibodies. Immunoglobulins provide a defense system against pathogenic microbes and toxins by targeting them for removal and/or destruction. Historically, antibodies have been thought to be composed of distinct structural domains known as the variable and constant regions that are responsible for antigen binding and mediating effector functions such as opsonization and complement activation, respectively. These domains were thought to be structurally and functionally independent. Recent work has revealed however, that in some families of antibodies, the two regions can influence each other. We will discuss the body of work that led to these observations, as well as the mechanisms that have been proposed to explain how these two different antibody regions may interact in the function of antigen binding.Entities:
Keywords: constant region; function; immunoglobulin; isotype; structure; variable region
Year: 2016 PMID: 26870003 PMCID: PMC4740385 DOI: 10.3389/fmicb.2016.00022
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Crystal structure of intact IgG. Adapted from Harris et al. (1998).
Summary of studies finding mAb isotype differences in Ag binding.
| 1991 | When CL and CH1 residues were substituted in mIgG1, 2a, and 2b Fab isotypes, differences in Ag binding using HSQC NMR were seen. | Kato et al., |
| 1993 | Murine IgG3 isotype was shown to self-aggregate through non-covalent Fc–Fc interactions, thereby causing differences in affinity for and binding to multivalent Ags as compared to its IgG1 isotype. | Greenspan and Cooper, |
| 1996 | hIgA1, hIgG1, hIgG2, and hIgG4 isotypes were found to have different KD constants using SPR. | Pritsch et al., |
| 2002 | mIgG1, and mouse-human chimeras (murine V-region with human constant regions 1, 2, 3, 4, M, and A1) were seen to have different Ag binding profiles by ELISA and Immunofluorescence. | McLean et al., |
| SPR studies showed no changes in thermodynamics upon deglycosylation of mIgG1, as well as significant differences between mIgG1 and its chimera. | ||
| 2005–2015 | mIgG1, 2a, 2b, and 3 isotypes were shown to have different Ag binding profiles and kinetics using ELISA, Immunofluorescence, ITC and SPR. They were further found to have differences in Trp fluorescence, CD spectroscopy with multivalent Ag, and chemical shifts by NMR when binding to a monovalent Ag. Monovalent peptide Ag cleavage assays revealed different abilities to cleave Ag as well as different rates of cleavage between the isotypes that cleaved. | Torres et al., |
| 2012 | A human IgG1 and its IgGA2 isotype were found to have differences in HIV-1 gp41 epitopes as well as Ag affinities measured by ELISA. | Tudor et al., |
| 2012–2013 | mIgG1, 2a, 2b, and 3 isotypes displayed differences in affinity to the same Ag using SPR methods, as well as isotype differences in Trp fluorescence and CD spectroscopy upon Ag binding. | Xia et al., |
| 2013 | mIgG1, 2a, 2b, and 3 isotypes were found to have different affinities to Ag using SPR. | Hovenden et al., |
| 2013 | Human IgG1 and IgA2 found to have different affinities for HIV-1 Env Ag by SPR. | Tomaras et al., |
| 2015 | Human IgG, IgA, IgE isotypes compared by SPR, found to have different Ag affinities. | Dodev et al., |
Unique antibodies with variable-region-identical isotype-switch variants and identifiable amino acid sequences.
| 2 | HGAC 39.G3, G1, G2b | Murine | Y | IGKV2-109*04 | IGHV6-3*01 | Greenspan and Cooper, |
| 4 | F105 mAb anti-gp120 G1, G3 | Human | N | IGKV3-20*01 | IGHV4-59*01 | Marasco et al., |
| 5 | anti-tubulin mAb | Human | Y | IGKV2-28*01 | IGHV3-73*02 | Pritsch et al., |
| 6 | IF6, 1E1, 2E12 mAbs anti-O6 LPS | Murine | N | IGKV1-110*01 | IGHV1S137*01 | Pollack et al., |
| 8 | 18B7 anti-GXM | Murine | Y | IGKV1-110*01 | IGHV5-6-2*01 | Mukherjee, |
| 10 | F425 mAb anti-gp140 G2, G1, G3, A | Human | Y | IGKV1D-33*01 | IGHV3-64*01 | Liu et al., |
| 11 | 3E5 anti-GXM | Murine | Y | IGKV1-110*01 | IGHV5-6-2*01 | Mukherjee, |
| 14 | F240 mAb anti-HIV G1, G3, G4 | Human | N | IGKV4-1*01 | IGHV3-11*04 | Cavacini et al., |
| 15 | F598 mAb anti-PNAG G2, G1 | Human | N | IGLV4-69*01 | IGHV4-59*01 | Kelly-Quintos et al., |
| 16 | F628 mAb anti-PNAG G2, G1 | Human | N | IGLV4-69*01 | IGHV4-59*01 | Kelly-Quintos et al., |
| 17 | F630 mAb anti-PNAG G2, G1 | Human | N | IGLV4-69*01 | IGHV1-18*04 | Kelly-Quintos et al., |
| 18 | 2G8, 1E12 mAbs anti-beta glucan G2b, M | Murine | Y | IGKV1-133*01 | IGHV1-9*01 | Torosantucci et al., |
| 20 | 12.8 mAb anti-pfMSP1 | Murine | Y | IGKV4-70*01 | IGHV9-1*02 | Porter and Press, |
| 21 | 12.10 mAb anti-pfMSP1 | Murine | Y | IGKV6-17*01 | IGHV1S81*02 | Porter and Press, |
| 23 | 2F5 bNAb anti-HIV1 G1, A2 | Human | Y | IGKV1-13*02 | IGHV2-5*02 | Kunert et al., |
| 24 | C1 mAb anti-pfMSP1 G1, G2a, G2b, G3 | Murine | N | IGKV8-28*01 | IGHV1-85*01 | Adame-Gallegos et al., |
| 27 | IgA1 and IgG1 crystallized Fabs | Human | Y | IGKV2-28*01 | IGHV3-73*02 | Correa et al., |
| 28 | F24F2 mAb anti-γdPGA | Murine | Y | IGKV1-135*01 | IGHV10-1*02 | Kozel et al., |
| 29 | F26G3 mAb anti-γdPGA | Murine | Y | IGKV1-135*01 | IGHV10-1*02 | Kozel et al., |
| 30 | PL9-11 mAb G3, G1, G2a, G2b | Murine | Y | IGKV8-28*02 | IGHV5-9*04 | Xia et al., |
| 34 | FI6 bNAb anti-HA stalk G1, G2a, DA265 | Human | N | IGKV4-1*01 | IGHV3-30-3*02 | Porter, |
| 35 | PY102 mAb anti-HA head G1, G2a, DA265 | Murine | N | IGKV8-28*01 | IGHV5-9*04 | Zaghouani et al., |
| 41 | PGT121 | Human | N | IGLV3-21*02 | IGHV4-4*08 | Walker et al., |
| 45 | 20B1 G1, G2a, G2b | Murine | N | IGKV9-124*01 | IGHV9-4*02 | French et al., |
Figure 2Relationships between permissive and non-permissive V region sequences. Immunoglobulins with differing C regions and identical V regions were identified in the literature (Table 2). VH and VL amino acid sequences were found for 24 of these unique antibodies (11 human and 13 murine, Table 2). Human sequences were grouped by (A) VH and (B) VL sequences. Murine sequences were also grouped by (C) VH and (D) VL sequences. For each group, a dendrogram was constructed through hierarchical average-linkage clustering with pairwise sequence similarity calculated as the Levenshtein distance. Leaf labels in the dendrograms are colored according to whether changes in the constant region for that antibody were permissive (green) or non-permissive (red) of specificity changes. The top V-region gene candidate for each amino acid sequence was determined with the IGBLAST blastp program using default parameters for either the human or mouse database (IGBLAST). Leaf labels in the dendrograms are of the form “seqID_top V-region gene hit,” where seqID matches the sequence ID given in Table 2.